Document is current

Article History

Received: 23 June 2023

Accepted: 26 September 2023

First Online: 21 October 2023

Declarations

:

: Eyal Leshem reports speaker honoraria from Novartis and GSK, personal fees from Sanofi Pasteur and Moderna, and personal fees from World Health Organization outside the submitted work. Naama Halpern reports speaker honoraria from Merck, MSD, and BMS and personal fees from Roche outside the submitted work. Talia Golan has received honoraria from Merck Sharp and Dohme, has acted in a consulting or advisory role for Abbvie, AstraZeneca, Bayer, Merck Sharp and Dohme, and Teva, has been on a speakers’ bureau for Abbvie and AstraZeneca, and has received research funding from AstraZeneca and Merck Sharp and Dohme all outside the submitted work. Ben Boursi, Einat Shacham-Shmueli, Einav Gal-Yam, Ofer Margalit, Tamar Beller, Gal Strauss, and Dafna Yahav declare that they have no competing interests.

: This research is in compliance with ethical standards. The research was approved by the Institutional Review Board (IRB) committee of Sheba Medical Center (SMC-9194–22). A waiver was given for informed consent since the study is a retrospective medical file-based research.